产品搜索 抗体高级搜索

首页 > 产品列表 > 一抗 > 细胞生物学

Anti-Human Kappa-R-phycoerythrin

产品编号:K103

产品描述:Anti-Human Kappa-R-phycoerythrin

反应种属:human

实验方法:FC

标记:

规格:0.2 mg

供应商:leinco

价格(RMB):4500.00

订购:订购

说明书:

Anti-Human Kappa R-phycoerythrin (R-PE)
Monoclonal Antibody

Prod. No.: K103
Clone:       HP6156
Isotype:    Mouse IgG1
Conc.:      0.1 mg/ml
Pkg. Size:    0.2 mg

Description
Specificity:
Anti-Human Kappa is specific for kappa light chains of human immunoglobulins. This antibody also recognizes free kappa light chains and Bence-Jones kappa light chains. It is not reactive with lambda light chains. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Antigen Distribution:
Approximately 50% of normal human B-lymphocytes express kappa light chains. B-cell leukemias may express either kappa or lambda light chains.

Reporter Molecule:
R-phycoerythrin (R-PE) has a molecular weight of 240 kDa and is purified from red algae. R-PE is an intensely bright phycobiliprotein with an absorption maxima at approximately 496, 546 and 565 nm, and a fluorescence emission maximum of ~578 nm.

Host Species
Mouse
Formulation
This R-phycoerythrin (R-PE) conjugate is formulated in 0.01 M phosphate buffered saline (PBS) pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage and Stability
This R-PE conjugate is stable when stored at 2-8°C. Do not freeze.
Reported Applications
FC
FC: This antibody can be used at a concentration of ≤ 1 µg per 100 µl of whole blood (or per 1.0 x 106 cells in a 100 µl total staining volume).

References
1. Reimer, C. B. et al. (1984) Hybridoma 3:263
2. Jefferies, R. et al. (1985) Immunol. Letters 10:223

Related Products
Anti-Human Kappa-Allophycocyanin (Leinco Prod. No.: K121)
Anti-Human Kappa Purified (Leinco Prod. No.: K100)
Anti-Human Kappa-Biotin (Leinco Prod. No.: K101)
Anti-Human Kappa-Fluorescein (Leinco Prod. No.: K102)

Products are for research use only. Not for use in diagnostic or therapeutic procedures.